Komori
Kidswell Bio (4584) · RiskMaterialised

Impairment due to uncertainty surrounding future cash flows from the master cell bank business

First written in FY2020. 1 of 1 entries say "Materialised", first in FY2020. Latest entry: FY2020.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Goodwill impairment in the regenerative medicine and master cell bank businessA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2020MaterialisedAnnual report

    「The company recorded the full carrying amount of goodwill as an impairment loss after determining that there was uncertainty over future cash flows in the business relating to the development of the master cell bank.」

    Uncertainty over future cash flows was recognized in the master cell bank development business, and the full amount of goodwill, ¥173.969 million, was recognized as an impairment loss.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Kidswell Bio yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impairment due to uncertainty surrounding future cash flows from the master cell bank business | Kidswell Bio Corporation (4584) | Komori